Clinical Trial Update: The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction) [Phase 2, Phase 3]

View source ↗

Summary

The Dutch STRIDER trial investigating sildenafil for early-onset fetal growth restriction in Phase 2/3 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Fetal Growth Restriction | Phase 2, Phase 3 | Status: TERMINATED